Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of a new eye drop formulation for dry eye disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Allergan | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2017-11-17